FDA Investigator Massoud Motamed

Massoud Motamed has inspections in 7 countries as of 18 Aug 2023. Massoud Motamed has collaborated with a combinined 4562 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

18 Aug 2023

Investigator Role:

FDA Investigator

Redica ID:

100000362

Country:

Spain, United Kingdom of Great Britain and Northern Ireland, United States of America, China, India, Switzerland, Austria

Co-Investigator(s):

Aaron L Dunbar, Abdollah Koolivand, Adam C Hipko, Ademola O Daramola, Adrian Rodriguez, Alberto A Viciedo, Alicia M Mozzachio, Alison N Stieg, Anastasia I Onuorah, Anastasia M Shields, Andrea A Branche, Angela E Glenn, Angela Mock, Ann L Demarco, Anthony A Charity, Arie R Dyk, Ariel Cruz Figueroa, Atul J Agrawal, Azza Talaat, Barbara J Rincon, Bill Tacket, Jr, Bing Lin, Bonita S Chester, Brackens Harris, Brandon K Barbee, Brian D Nicholson, Brooke K Higgins, Brooke K Seeman, Burnell M Henry, Camerson E Moore, Carol A Declouette Wilburn, Casey L Hamblin, Cathleen A Castellaw, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Chad J Whitwell, Chaltu N Wakijra, Charles B Steinmiller, Charles D Brown, Cheryl A Clausen, Chmura, Christopher D Rush, Christopher J Hurst, Christopher J Smith, Christopher L Jacobs, Christopher S Keating, Claire M Minden, Crystal S Harris, Crystal S Harris Smith, Dallas E Gilbreath Jr, Dana M Lewis, Daniel J Lahar, Daniel J Roberts, Danielle Lyke, Danny D Horner, Darla J Christopher, David M Beltran, Debra D Devlieger, Debra Devlieger, Denise Connelly, Dennis Cantellops Paite, Dennis L Doupnik, Diane L Raccasi, Diane T Bargo, Diane T O'brien, Dipesh K Shah, Douglas A Campbell, Dr. Carmelo Rosa, Edmund F Mrak, Jr, Edward D Edmiston, Elizabeth D Connell, Elkins, Elmina E Akwo, Elmina E Mboh, Emest F Bizjak, Eric M Mueller, PharmD, Erika V Butler, Farhana Khan, Felix Maldonado, Franklin R Harris, Frans E Mercado, Gam S Zamil, George Pyramides, Gery M Duparc, Grant, Grant L Davis, Guerlain Ulysse, Guo Q Shen, Gwyn G Dickinson, H Ljamilla Selby, Habacuc V Barrera, Haijing Hu, Hala L Selby, Hung V Le, James L Dunnie, Jr, James M Mason, Jamie M Bumpas, Janet A Rajan, Janice M Hickok, Jay V Jariwala, Jeffrey P Raimondi, Jeffrey R Wooley, Jennifer Lalama, Jennifer Owens Dowdy, Jodi M Gatica, Joel D Hustedt, Jogy George, Johann M Fitch, John P Mistler, Johnna L Bleem, Jonaida Estevez Martinez, Jonathan A Womack, Jonathan W Chapman, Jose Acruz Gonzalez, Jose E Melendez, DDC, Jose Martinez, Jr, Joseph E Duran, June P Page, Justin A Boyd, Kamara Tx, Karen C Daugherty, Karlton T Watson, Katelyn Astaub Zamperini, Katherine E Jacobitz, Katherine Szestypalow, Kellia N Hicks, Kenitra D Hewitt, Kevin A Gonzalez, Kevin D Kallander, Kevin T Nguyen, Kham Phommachanh, Kimberley A Hoefen, Ko U Min, Kshitij A Patkar, Lance Sindo, CIH, CQA, RS, Lata C Mathew, PhD, Latorie S Jones, Laurie B Frazier, Laurimer Kuilan Torres, Lawrence Harmon, Jr, Lawrence J Stringer, LCDR Chad N Thompson, Liming Zhang, Linda F Murphy, Lisa L Flores, Lisa M Puttonen, Lisa M Yoder, Lisa R Jennings, Lisa R Whitt, Lloyd D Payne, Loan T Tran, Loisa R Jennings, Lori G Cantin, Lorie S Hannappel, Lourdes R Genera, Lucas B Leake, Mada A Tautges, Makini Cobourne Duval, PhD, Marcellinus D Dordunoo, Marcus A Ray, Margaret M Annes, Martha S Baldwin, Martinez, Matthew R Maddox, Matthew R Sleeter, Melissa J Garcia, Melissa T Roy, Michael A Charles, Michael A Taylor, Michael L Jones, Michelle Marsh, Monique Rac Lester, Mra B Kamberem, Mra Davism, Mra M Barbosar, Mra Munizn, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy M Espinal, Navista C Bolton, Nimmy Mathews, Pankaj H Amin, Parul M Patel, Patrice S Hall, Patty P Kaewussdangkul, Paul A Bonneau, Paul E Frazier, Paula J Bretz, Peter E Baker, Philip M Steele, PhD, Pratik S Upadhyay, DDC, Priya J Rathnam, Qin Xu, Rabin N Ghoshal, Rafael E Arroyo, Rafeeq A Habeeb, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Robert C Steyert, Robert D Tollefsen, Robert J Martin, Robert T Lorenz, Rodriguez, Saleem A Akhtar, Sandy J Ziegler, Sangeeta M Khurana, PhD, Sara Rothman, Sarah Forney, Satheesh Thomas, Scott T Ballard, Sean R Marcsisin, Seri L Essary, Sha'tina R Alridge, Shanna N Purdy, Sharon K Thoma, PharmD, Shelby N Marler, Shelby N Turner, Sherrie L Krolczyk, Sherrie L Krolezyk, Simone E Pitts, Sneha Patel, Sneha S Patel, Staci G Mcallister, State Agency, Stefanie L Heckman, Stefanie L Kremer, Stephen D Brown, Stephen D Eich, Stephen L Beekman, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susanna E Ford, Analyst, Suzanne N Vallez, Tamera H Hunt, Tamika White, Tamil Arasu, PhD, Tara A Gray, Tara G Bizjak, Thomas J Arista, Thomas S Arista, Toby Vern H Hill, Tomika L Bivens, Tonia F Bernard, Torrance J Slayton, Toyin B Oladimeji, Tricia S Martinez, Trina K Vick, Truong Xuan Nguyen (Andy), Tsedenia Woldehanna, Unnee Ranjan, Vilmary Negron Rodriguez, Walden H Lee, Wayne E Seifert, William A Warnick, William L Bargo, Xiaokuang Lai, PhD, Yvins Dezan

Massoud Motamed's Documents

Publish Date	Document Type	Title
September, 2016	FDA 483	Mylan Laboratories Limited - Form 483, 2016-09-14
November, 2016	FDA 483 Response	Mylan Pharmaceuticals Inc. - Form 483R, 2017-02-13
August, 2017	FDA 483	Emcure Pharmaceuticals Limited - Form 483, 2017-08-17
January, 2017	FDA 483	Fujifilm Ultra Pure Solutions Inc. - Form 483, 2017-01-12
July, 2016	FDA 483	US Compounding Inc - Form 483, 2015-08-21
May, 2017	FDA 483	Zhejiang Huahai Pharmaceutical Co., Ltd. - Form 483, 2017-05-19
January, 2017	FDA 483	AstraZeneca Pharmaceuticals LP - Form 483, 2017-01-30
September, 2016	FDA 483	Megafine Pharma (P) Limited - Form 483, 2016-09-23
February, 2017	FDA 483	Preferred Homecare (Park Infusioncare LP) - Form 483, 2017-02-17
August, 2017	FDA 483	BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED - Form 483, 2017-08-04
March, 2016	FDA 483 Response	AstraZeneca Pharmaceuticals LP - Form 483R, 2016-04-19
November, 2015	FDA 483	Mary Kay, Inc - Form 483, 2015-11-17
October, 2015	EIR	Goodier Cosmetics - EIR, 2015-10-08
May, 2017	EIR	Zhejiang Huahai Pharmaceutical Co., Ltd. - EIR, 2017-05-19
July, 2016	FDA 483	Bachem SA, succursale de Vionnaz - Form 483, 2016-07-01
October, 2015	FDA 483	Goodier Cosmetics - Form 483, 2015-10-08
January, 2017	FDA 483 Response	AstraZeneca Pharmaceuticals LP - Form 483R, 2017-02-10
July, 2016	FDA 483	US Compounding Inc - Form 483, 2016-07-15
June, 2016	FDA 483	Laboratoire Sintyl S.A. - Form 483, 2016-06-23
July, 2015	EIR	Allergan Sales, LLC - EIR, 2015-07-10
April, 2015	FDA 483	B & P Industrial Inc. - Form 483, 2015-04-01
June, 2015	FDA 483	Vita Pharmacy, LLC dba Talon Compounding Pharmacy - Form 483, 2015-06-24
December, 2015	FDA 483	Pan Drugs Limited - Form 483, 2015-12-03
February, 2016	FDA 483	I.V. Specialty, Ltd - Form 483, 2016-02-05
October, 2016	FDA 483	Allergan Sales, LLC - Form 483, 2016-10-28
May, 2015	FDA 483	Blue Bell Creameries, L.P. - Form 483, 2015-05-01
February, 2016	FDA 483	CTX Lifesciences Pvt. Ltd. - Form 483, 2016-02-19
October, 2016	EIR	Allergan Sales, LLC - EIR, 2016-10-28
May, 2016	FDA 483	Interquim, S.A. - Form 483, 2016-05-06
October, 2015	FDA 483 Response	Goodier Cosmetics - Form 483R, 2015-10-28
November, 2016	EIR	Mylan Pharmaceuticals Inc. - EIR, 2016-11-18
May, 2015	FDA 483 Response	Blue Bell Creameries, L.P. - Form 483R, 2015-05-22
April, 2016	FDA 483	PURAC BIOQUIMICA SA - Form 483, 2016-04-21
December, 2016	FDA 483	Hetero Labs Limited - Form 483, 2016-12-16
May, 2017	FDA 483	Shandong Vianor Biotech Co., Ltd. - Form 483, 2017-05-10
July, 2015	FDA 483	Allergan Sales, LLC - Form 483, 2015-07-10
November, 2016	FDA 483	Mylan Pharmaceuticals Inc. - Form 483, 2016-11-18
March, 2016	FDA 483	AstraZeneca Pharmaceuticals LP - Form 483, 2016-03-29
December, 2015	FDA 483	SOFTECH PHARMA PRIVATE LIMITED - Form 483, 2015-12-11
June, 2017	FDA 483	Cantrell Drug Company - Form 483, 2017-06-29
December, 2016	EIR	Hetero Labs Limited - EIR, 2016-12-16
May, 2017	FDA 483	Bicooya Cosmetics Limited - Form 483, 2017-05-25
December, 2016	FDA 483	DIVI'S LABORATORIES LIMITED - Form 483, 2016-12-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more